Keith S Manchester Roivant Sciences Ltd. (ROIV) insider trading activity

Keith S Manchester is of Roivant Sciences Ltd.. Currently has a direct ownership of 1.95 Million shares of ROIV, which is worth approximately $38.9 Million. The most recent transaction as insider was on Sep 10, 2025, when has been sold 14,524 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.95M

52.56% 3M change

52.56% 12M change

Total Value Held $38.9 Million

KEITH S MANCHESTER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 10 2025	BUY Grant, award, or other acquisition	-	14,524 Added 0.74%	1,948,403 Common Shares
Sep 25 2024	SELL Open market or private sale	$1,588,337 $11.77 p/Share	134,948 Reduced 9.56%	1,277,178 Common Shares
Sep 24 2024	SELL Open market or private sale	$4,276,764 $11.62 p/Share	368,052 Reduced 20.68%	1,412,126 Common Shares
Sep 10 2024	BUY Grant, award, or other acquisition	-	16,406 Added 0.91%	1,780,178 Common Shares
Sep 12 2023	BUY Grant, award, or other acquisition	-	17,825 Added 20.3%	69,967 Common Shares
Sep 15 2022	BUY Grant, award, or other acquisition	-	52,142 Added 50.0%	52,142 Common Shares

Also insider at

ABUS

Arbutus Biopharma Corp Healthcare

Director

KSM